Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Cost implications to health care payers of improving glucose management among adults with type 2 diabetes.

Nuckols TK, McGlynn EA, Adams J, Lai J, Go MH, Keesey J, Aledort JE.

Health Serv Res. 2011 Aug;46(4):1158-79. doi: 10.1111/j.1475-6773.2011.01257.x. Epub 2011 Apr 1.

2.

Cost implications of improving blood pressure management among U.S. adults.

Nuckols TK, Aledort JE, Adams J, Lai J, Go MH, Keesey J, McGlynn E.

Health Serv Res. 2011 Aug;46(4):1124-57. doi: 10.1111/j.1475-6773.2010.01239.x. Epub 2011 Feb 9.

3.

Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.

Menzin J, Korn JR, Cohen J, Lobo F, Zhang B, Friedman M, Neumann PJ.

J Manag Care Pharm. 2010 May;16(4):264-75.

4.

Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.

Yu AP, Wu EQ, Birnbaum HG, Emani S, Fay M, Pohl G, Wintle M, Yang E, Oglesby A.

Curr Med Res Opin. 2007 Sep;23(9):2157-69. Review.

PMID:
17669232
5.
6.
10.

Quality measure attainment in patients with type 2 diabetes mellitus.

Lafeuille MH, Grittner AM, Gravel J, Bailey RA, Martin S, Garber L, Sheng Duh M, Lefebvre P.

Am J Manag Care. 2014 Jan;20(1 Suppl):s5-15.

11.

Cost-effectiveness of automated telephone self-management support with nurse care management among patients with diabetes.

Handley MA, Shumway M, Schillinger D.

Ann Fam Med. 2008 Nov-Dec;6(6):512-8. doi: 10.1370/afm.889.

12.

Economic evaluation of Indigenous health worker management of poorly controlled type 2 diabetes in north Queensland.

Segal L, Nguyen H, Schmidt B, Wenitong M, McDermott RA.

Med J Aust. 2016 Mar 21;204(5):1961e-9.

PMID:
26985851
14.

Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland.

Brändle M, Erny-Albrecht KM, Goodall G, Spinas GA, Streit P, Valentine WJ.

Int J Clin Pharmacol Ther. 2009 Aug;47(8):501-15.

PMID:
19640359
15.

Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China.

Palmer JL, Gibbs M, Scheijbeler HW, Kotchie RW, Nielsen S, White J, Valentine WJ.

Adv Ther. 2008 Aug;25(8):752-74. doi: 10.1007/s12325-008-0080-4.

PMID:
18704282
16.
17.

Medical costs of managed care in patients with type 2 diabetes mellitus.

Bhattacharyya SK, Else BA.

Clin Ther. 1999 Dec;21(12):2131-42.

PMID:
10645758
18.

Economic costs of diabetes in the U.S. In 2007.

American Diabetes Association.

Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Review. Erratum in: Diabetes Care. 2008 Jun;31(6):1271.

PMID:
18308683
19.

Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US.

Ray JA, Valentine WJ, Roze S, Nicklasson L, Cobden D, Raskin P, Garber A, Palmer AJ.

Diabetes Obes Metab. 2007 Jan;9(1):103-13.

PMID:
17199725
20.

Supplemental Content

Support Center